Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy.

Shah KP, Song H, Ye F, Moslehi JJ, Balko JM, Salem JE, Johnson DB
Cancer Immunol Res. 2020 8 (7): 851-855

PMID: 32350001 · PMCID: PMC7334081 · DOI:10.1158/2326-6066.CIR-19-0986

MeSH Terms (19)

Adolescent Adult Aged Aged, 80 and over Age Factors Antineoplastic Agents, Immunological CTLA-4 Antigen Female Hospitalization Humans Immunologic Factors Immunotherapy Length of Stay Male Melanoma Middle Aged Programmed Cell Death 1 Receptor Risk Factors Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: